Society for Medicines Research (SMR) shared a post on LinkedIn:
“Speaker Spotlight: Target ID and Validation in Drug Discovery – Oct 24th, 2025.
We are excited to welcome Dr Andrzej Mazan, Associate Director at Ryvu Therapeutics, as one of our distinguished speakers at the Target Identification and Validation Meeting organised by SMR!
- 24th October 2025
- AstraZeneca Discovery Centre, Cambridge, UK
- Registration.
Don’t miss out – register now and be part of this exceptional scientific event!”
